Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkin's lymphomas.
about
Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agentPixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomasThe European Medicines Agency review of pixantrone for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphomas: summary of the scientific assessment of the committee for medicinal products for hLong-Term Response and Remission with Pixantrone in Patients with Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma: Post-Hoc Analysis of the Multicenter, Open-Label, Randomized PIX301 Trial.Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells
P2860
Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkin's lymphomas.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Phase-II study of the new aza- ...... ssive non-Hodgkin's lymphomas.
@ast
Phase-II study of the new aza- ...... ssive non-Hodgkin's lymphomas.
@en
type
label
Phase-II study of the new aza- ...... ssive non-Hodgkin's lymphomas.
@ast
Phase-II study of the new aza- ...... ssive non-Hodgkin's lymphomas.
@en
prefLabel
Phase-II study of the new aza- ...... ssive non-Hodgkin's lymphomas.
@ast
Phase-II study of the new aza- ...... ssive non-Hodgkin's lymphomas.
@en
P2093
P1433
P1476
Phase-II study of the new aza- ...... essive non-Hodgkin's lymphomas
@en
P2093
Andreas Engert
Anne Parry
Christian Gisselbrecht
Christian Rudolph
Derigs Michael Pfreundschuh
Franck Morschhauser
Gabriella Camboni
Hans Günther
Jean Luc Harousseau
Martin Wilhelm
P304
P577
2003-08-01T00:00:00Z